Invest in US

Overview

The market for AI-driven advancements in the life sciences sector is poised for exponential growth. The AI in drug discovery market is anticipated to grow from $1.5 billion in 2022 to $20.9 billion by 2032, representing a compound annual growth rate (CAGR) of 30.1%. This growth is driven by AI's potential to streamline drug discovery processes, significantly reducing time-to-market and development costs. These advancements are especially valuable in light of recent global health challenges, which have underscored the importance of rapid innovation in drug development. With these compelling growth figures, the AI-driven drug discovery sector presents a high-value investment opportunity in a market that is likely to play an increasingly crucial role in global healthcare solutions. By the way, check out our vision.

Similarly, the broader drug discovery market, which encompasses both traditional and AI-enhanced methods, is projected to expand from $100.10 billion in 2024 to $137.72 billion by 2029, at a CAGR of 6.59%. This growth is supported by continued investment in new therapeutic areas, regulatory support for faster drug approvals, and the integration of automation and AI to meet the demand for quicker, more efficient discovery pipelines. For investors, this dual-market scenario – where AI-driven niche applications are enhancing a large, stable base market will offer a diversified opportunity with potential for substantial returns. As AI and automation become integral to drug discovery, investors will have the opportunity to capitalize on both immediate growth prospects and long-term industry shifts poised to redefine the pharmaceutical landscape.

Vision

At Akshar Innovation, we are commited to revolutionizing health care through innnovative solutions that address the most pressing challenge in medicine today. From heart health to advance imaging, our mission is to enhance patient care and drive medical progress.

We are the team of young, passionate scientists and medical practitioner who are defined by three Ds, Daring, Diligent, and Dedicated. We seek out challenging problems and strive to provide simpler solutions. Our activity will be centred around five C's: Compete, Co-exist, Cooperate, Confront, Contest.

Insight

The need of novel therapeutics, increased manufacturing capacities in the life sciences industry, and technological advancements facilitate the demand for automated solutions.Furthermore, the demand for the Quantum-AI powered solution in health-care is rising due to rising prevalence of chronic diseases.

Contact

• Twitter
• Facebook
• Instagram
• GitHub

Elements

i = 0;

while (!deck.isInOrder()) {
    print 'Iteration ' + i;
    deck.shuffle();
    i++;
}

print 'It took ' + i + ' iterations to sort the deck.';